<SEC-DOCUMENT>0001193125-26-345732.txt : 20260812
<SEC-HEADER>0001193125-26-345732.hdr.sgml : 20260812
<ACCEPTANCE-DATETIME>20260812071520
ACCESSION NUMBER:		0001193125-26-345732
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260812
DATE AS OF CHANGE:		20260812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TScan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001783328
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				825282075
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40603
		FILM NUMBER:		261265304

	BUSINESS ADDRESS:	
		STREET 1:		830 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		857-399-9500

	MAIL ADDRESS:	
		STREET 1:		830 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tcrx-20260812.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-08-11T18:06:32.9022+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:tcrx="http://www.tscan.com/20260812" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_d1a9b7db-0a62-4e0d-82eb-f37300da0725" name="dei:AmendmentFlag" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_d760345b-7c8e-4afe-9605-349b5a6c307f" name="dei:EntityCentralIndexKey" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139">0001783328</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrx-20260812.xsd"/></ix:references><ix:resources><xbrli:context id="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-12</xbrli:startDate><xbrli:endDate>2026-08-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bbdd4981-9042-4e03-9ad3-56e0371d0dd5" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:40.4%;box-sizing:content-box;"/>
     <td style="width:59.6%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">                                                               </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:0.398%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_e77c4917-57eb-4c66-8f3f-89f487e4743e" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 12, 2026</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:24pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;"><ix:nonNumeric id="F_9fd94b82-cc58-4054-a06d-02115ef47a37" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TSCAN THERAPEUTICS, INC.</span></ix:nonNumeric></span></p><p style="font-size:7.5pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:19.196%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:20.196%;box-sizing:content-box;"/>
     <td style="width:18.176%;box-sizing:content-box;"/>
     <td style="width:41.412%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0160cf1a-05bd-46e3-9ff1-5abe0c9dfc2a" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b8d704d1-a331-4f68-be60-43f39da1ab07" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-40603</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9ad1f1e6-af86-4291-bdb0-47be9122507b" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">82-5282075</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(State or other jurisdiction<br/>of incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cf744699-615a-410d-9dc0-9901ab0ecb2c" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">830 Winter Street</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_3941c46c-f23b-420a-9a05-2d68da124724" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Waltham</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_ceb526b9-1ca6-4352-ae6b-462c4e9b6c13" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b05ae731-191d-4f52-ac37-71af497a65c9" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02451</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:44.44%;box-sizing:content-box;"/>
     <td style="width:55.56%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:0.398%;text-align:left;"><span><ix:nonNumeric id="F_20353636-c95a-4915-a5db-66d697a239e9" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> 857</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_d8dc2705-7023-48af-bcd6-bf721f447279" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">399-9500</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="border-top:0.5pt solid;padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Not Applicable</span></p><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:3%;box-sizing:content-box;"/>
     <td style="width:91%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_5ab8d3a8-65a8-4345-8e7a-e174a3de6993" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_4e301d95-cd9b-4bcc-a1a3-029055129ec9" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_5a47d2ac-db54-46e7-80bf-6a79febcb92b" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_cf28df02-b871-4eb1-bb79-fc74ddda58f8" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_397bdd70-dd84-4b37-b485-cd5f85ab6ca2" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Voting Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e3fb1e6f-09d4-417f-b0d2-5559e0bfb7c4" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TCRX</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d7891ba0-d892-4840-a3d8-cb8dae6c27bd" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market, LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c459f6de-3964-434d-80f2-945cc9c8d8ff" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6924267-c672-4793-bf49-9ec6048efa9d" contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></h2><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 12, 2026, TScan Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></h2><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall neither be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.</span></h2><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></h2><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:</span></h2>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:89%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release issued by TScan Therapeutics, Inc., dated August 12, 2026.</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 12, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gavin MacBeath, Ph.D.</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tcrx-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-08-11T18:06:32.9631+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img207367504_0.jpg" alt="img207367504_0.jpg" style="width:192px;height:56px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">First patient dosed in Phase 3 ALLOHA-2&#153; study; topline readout expected mid-2028</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Shared positive initial data from Cohort C of Phase 1 ALLOHA&#153; study, validating internal commercial-ready manufacturing process</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and cash equivalents fund operations into the second quarter of 2027</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">WALTHAM, Mass., Aug 12, 2026 --</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today reported financial results for the three months ended June 30, 2026, and provided a corporate update.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;This is a transformative time for TScan with our first pivotal study now enrolling at major transplant centers across the U.S.,&#x201d; said Gavin MacBeath, Ph.D., Chief Executive Officer. &#x201c;A key priority during the first half of this year was demonstrating the performance of our improved commercial-ready manufacturing process. Data from Cohort C of the ALLOHA trial, generated using this process, reinforces our confidence in both our manufacturing and the clinical potential of TSC-101 as we enter our Phase 3 study. Building on the encouraging efficacy we have observed with TSC-101, we are also expanding our heme program to address additional HLA types, with Phase 1 trials of TSC-102-A01 and TSC-102-A03 expected to begin in the fourth quarter of this year.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Recent Corporate Highlights</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In July, the Company </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">announced</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> that it has dosed the first patient in the ongoing Phase 3 ALLOHA-2&#153; clinical trial evaluating TSC-101 for the treatment of patients with heme malignancies undergoing allogeneic hematopoietic cell transplantation (allo-HCT). The Company anticipates completion of enrollment and reporting of topline data from this pivotal study mid-2028. </font></div></div><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In June, the Company </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">reported</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> positive initial data from Cohort C of the Phase 1 ALLOHA&#153; study (</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">NCT05473910</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">) and additional patient characteristics are described below.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">~90% first-pass manufacturing success rate (17/19) with commercial-ready process.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Most patients enrolled in Cohort C had poor prognostic features, with 86% of patients (12/14) being minimal residual disease (MRD)-positive prior to transplant and 86% (12/14) having mixed donor chimerism at their first assessment post-transplant. </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Despite having aggressive disease with a high risk of relapse, patients infused with TSC-101 have demonstrated meaningful clinical benefit from the product candidate. 79% of patients (11/14) achieved complete donor chimerism within ~three weeks of receiving their first infusion of TSC-101; an additional two had improving chimerism following TSC-101, which is consistent with eliminating residual cancer cells and correlates with preventing post-transplant relapse.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TSC-101 continued to be well-tolerated, with observed safety consistent with post-HCT adverse events.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In June, the Company </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">announced</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> that it has entered into an agreement with Cellares, the first integrated development and manufacturing organization (IDMO), to assess Cellares&#x2019; fully automated Cell Shuttle</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and Cell Q&#153; platforms as a potentially scalable and cost-efficient path to commercial manufacturing. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pipeline Progress and Upcoming Anticipated Milestones</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Heme Malignancies Program: TScan&#x2019;s lead TCR-T therapy candidate, TSC-101, is designed to treat residual disease and prevent relapse in patients with heme malignancies undergoing allogeneic HCT (ALLOHA-2&#153; trial, </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">NCT07702578</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">).</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Share updated data on patients treated in Cohort C of the Phase 1 ALLOHA&#153; study in the fourth quarter of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Initiate Phase 1 study of TSC-102-A01 and TSC-102-A03 in the fourth quarter of 2026 with initial data in 2027. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Share updated data, inclusive of over 1-year of follow-up time, on Cohort C patients of the ALLOHA study in the first half of 2027.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Solid Tumor Program: The Company&#x2019;s strategy is to treat patients with multiple TCR-T therapy candidates to overcome tumor heterogeneity.</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Currently developing methods to engineer TCR-Ts </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> to treat solid tumors, with initial candidates in preclinical development. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Established a roadmap for filing an investigational new drug (IND) application by H2 2027 after recent INTERACT engagement with the U.S. Food and Drug Administration (FDA).</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Autoimmunity Program: The Company has discovered novel targets for ankylosing spondylitis and other HLA-B*27-associated autoimmune disorders and is currently developing potential treatment options.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Second Quarter 2026 Financial Results</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue for the second quarter of 2026 was $1.1 million, compared to $3.1 million for the second quarter of 2025. The decrease was primarily due to timing of research activities pursuant to the Company&#x2019;s collaboration agreement with Amgen.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">R&amp;D Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development (R&amp;D) expenses for the second quarter of 2026 were $23.4 million, compared to $32.6 million for the second quarter of 2025. The decrease of $9.2 million was primarily driven by a decrease in laboratory supplies, research materials, and studies due to the timing in the purchase of supplies and consumables, and decrease spend on contracted services, as well as savings in connection with the Company&#x2019;s previously announced strategy to prioritize the clinical development of its heme program. R&amp;D expenses included non-cash stock compensation expense of $1.2 million and $1.7 million for the second quarter of 2026 and 2025, respectively.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">G&amp;A Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">General and administrative (G&amp;A) expenses for the second quarter of 2026 were $8.1 million, compared to $9.1 million for the second quarter of 2025. The decrease of $1.0 million was primarily due to a decrease in personnel costs. G&amp;A expenses included non-cash stock compensation expense of $1.2 million and $1.6 million for the second quarter of 2026 and 2025, respectively.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Net Loss: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss was $30.4 million for the second quarter of 2026, compared to $37.0 million for the second quarter of 2025, and included net interest income of $0.8 million and $2.4 million, respectively.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash Position: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash and cash equivalents as of June 30, 2026, were $100.2 million, excluding $5.0 million of restricted cash. The Company believes that its existing cash resources will be sufficient to fund its current operating plan into the second quarter of 2027. The Company did not achieve certain non-covenant related milestones by June 30, 2026 as provided under its existing debt agreement, therefore the updated cash runway reflects commencement of the two-year term loan amortization beginning in the fourth quarter of 2026.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Share Count: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">As of June 30, 2026, the Company had 67,779,255 issued and outstanding shares of common stock, consisting of 63,502,667 shares of voting common stock and 4,276,588 shares of non-voting common</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">stock, as well as 62,246,707 outstanding pre-funded warrants to purchase shares of voting common stock at an exercise price of $0.0001 per share. Pro forma outstanding shares, inclusive of both common stock and pre-funded warrants, were 130,025,962 as of June 30, 2026.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About TScan Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan is a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer. The Company&#x2019;s lead TCR-T therapy candidate, TSC-101, is in development for the treatment of patients with hematologic malignancies to prevent relapse following allogeneic hematopoietic cell transplantation (the ALLOHA-2&#153; Phase 3 pivotal trial). The Company is also in early stages of developing methods for </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> engineering to treat solid tumors. In addition, the Company is applying its target discovery platform to discover novel targets in various T cell-mediated autoimmune disorders.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, express or implied statements regarding TScan&#x2019;s plans, progress, expectations, and timing relating to the ALLOHA&#153; and ALLOHA-2&#153; clinical trials, including presentation of data and the implications of such results, enrollment and dosing of patients, and clinical trial design; plans, progress, expectations, and timing relating to TScan&#x2019;s TSC-102-A01 and TSC-102-A03 Phase 1 study; the evaluation of Cellares&#x2019;s fully automated manufacturing platforms being indicative of Cellares&#x2019;s successful manufacturing support of TScan&#x2019;s programs, including scalability and cost-effectiveness; TScan&#x2019;s plans, progress, and timing relating to TScan&#x2019;s solid tumor program, including preclinical development and submission of an IND application; TScan&#x2019;s plans, process, and timing relating TScan&#x2019;s autoimmunity program; the potential benefits of any of TScan&#x2019;s proprietary platforms or current or future product candidates in treating patients; TScan&#x2019;s ability to fund its operating plan into the second quarter of 2027 with its existing cash resources; and TScan&#x2019;s goals and strategy. TScan intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as, but not limited to, &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;target,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;plan,&#x201d; &#x201c;on track,&#x201d; or similar expressions or the negative of those terms. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions, and uncertainties. The express or implied forward-looking statements included in this release are only predictions and are subject to a number of risks, uncertainties and assumptions, including, without limitation: the beneficial characteristics, safety, efficacy, therapeutic effects and potential advantages of TScan&#x2019;s TCR-T therapy product candidates; TScan&#x2019;s expectations regarding its preclinical studies or clinical trials being predictive of future clinical trial results; TScan&#x2019;s cleared INDs being indicative or predictive of bringing TScan closer to its goal of providing customized TCR-T therapies to treat patients with cancer; the timing of the launch, initiation, progress, expected results and announcements of TScan&#x2019;s preclinical studies, clinical trials and its research and development programs; TScan&#x2019;s ability to enroll patients for its clinical trials within its expected timeline; TScan&#x2019;s plans relating to developing and commercializing its TCR-T therapy product candidates, if approved, including sales strategy; estimates of the size of the addressable market for TScan&#x2019;s TCR-T therapy product candidates; TScan&#x2019;s manufacturing capabilities and the scalable nature of its manufacturing process; TScan&#x2019;s estimates regarding expenses, future milestone payments and revenue, capital requirements and needs for additional financing; TScan&#x2019;s expectations regarding competition; TScan&#x2019;s anticipated growth strategies; TScan&#x2019;s ability to attract or retain key personnel; TScan&#x2019;s ability to establish and maintain development partnerships and collaborations; TScan&#x2019;s expectations regarding federal, state and foreign regulatory requirements; TScan&#x2019;s ability to obtain and maintain intellectual property protection for its proprietary platform technology and our product candidates; the sufficiency of TScan&#x2019;s existing capital resources to fund its future operating expenses and capital expenditure requirements; and other factors that are described in the &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; sections of TScan&#x2019;s most recent Annual Report on Form 10-K and any other filings that TScan has made or may make with the SEC in the future. Any forward-looking statements contained in this release represent TScan&#x2019;s views only as of the date hereof and should not be relied upon as representing its</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">views as of any subsequent date. Except as required by law, TScan explicitly disclaims any obligation to update any forward-looking statements.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Investor and Media Contact</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Caileigh Dougherty<br>AVP, Head of Corporate Communications &amp; Investor Relations<br>857-399-9890<br>cdougherty@tscan.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:68.772%;box-sizing:content-box;"></td>
     <td style="width:1.439%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.174999999999999%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.439%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.174999999999999%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheet Data</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(unaudited, in thousands, except share amount)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">June 30,<br>2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">December 31,<br>2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">100,156</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">152,406</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Other assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">71,296</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">76,383</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">171,452</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">228,789</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders' Equity</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">102,433</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">105,666</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total stockholders' equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">69,019</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">123,123</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' deficit</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">171,452</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">228,789</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Common stock and pre-funded warrants outstanding</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">&#160;(1)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">130,025,962</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">129,913,390</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(1) </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Includes at June 30, 2026 and December 31, 2025, respectively, 62,246,707 and 73,011,767 issued and outstanding pre-funded warrants to purchase shares of voting common stock at an exercise price of $0.0001 per share.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:68.772%;box-sizing:content-box;"></td>
     <td style="width:1.439%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.174999999999999%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.439%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.174999999999999%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Operations</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(unaudited, in thousands, except share and per share amounts)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Three Months Ended June 30,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</font></p></td>
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">1,051</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3,076</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">23,402</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">32,634</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8,142</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">9,095</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">31,544</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">41,729</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(30,493</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(38,653</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Interest and other income, net</font></p></td>
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">833</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">2,390</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Interest expense</font></p></td>
     <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(699</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(689</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(30,359</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(36,952</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(0.23</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(0.28</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Weighted average common shares outstanding&#x2014;basic and diluted </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(2)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">129,948,878</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">129,730,451</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(2)</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;For the three months ended June 30, 2026 and 2025, respectively, 62,246,707 and 73,087,945 shares of the Company's voting common stock issuable upon exercise of pre-funded warrants are included as outstanding common stock in the calculation of basic and diluted net loss per share.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img207367504_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img207367504_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %1!(,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@#Y7_;$_:-TO]E_X&>*?B+,]O-XFGC_ .$=^'^D7!5AJWC3
M58)UTP/"Q!FL=*BBNM>U>/,?F:;I=W;1RI<SVX;^,O6=8U/Q%J^JZ_K=_<ZI
MK6N:C?ZOJ^IWDC37FHZGJ5S+>:A?74S?-+<W=U--<32-AI))'?@8K]!/^"E?
M[4@_:*^.MWH?AK43=?"_X427_A?PD;>;?8ZUJ_GHGBGQ;'M+1RQ:I?6L.GZ3
M<1-)%-H>DZ=>P^5)?W*/^<]?JG#>5_4,%[2I&V)Q2C5JW6L*=G[*D_\ "FY3
M3U4Y2BU[D6?ZZ?1B\*?^(<\!TLQS/#>QXIXNCA\TS55(<M? 8#V;EE.4/F2E
M3>'H598K%TW&,XX[%UZ%3F6%I.)1117TA_2@4444 %%%% !1110 4444 %%%
M% !1110 4444 %?H-_P3C_:D/[-?QWL+;Q%J!M?A?\3FL?"?CH32;;/2+AKE
MQX;\82 D)'_PCVH7<\.H3$LL?A_5-;=8YKE+;9^?-%<^+PM+&8>KAJRO3K0E
M"6FJO9QE&^BE"24HNSLTCYWBWA?*N-.&\YX7SJC[;+,ZP-;!8B*2]I2<[3H8
MN@Y)J&)P6(A2Q>%J-/V>(HTYV?+9_P!]RL' 92&5@""#P>X((X((_/W!IU?E
MW_P2W_:D'QS^"B?#GQ5J/VCXD_!VVT_0[N2YE+7OB#P0RFW\*Z]F0^;<7-A%
M WAW6)?WT@FL=.O[^87.N(H_42OQC&86K@L36PM9>_1FXW6TXM)PG&_V9Q:D
MKZI-)V=TO\0^-N$<UX$XJSOA/.8<N.R;&U,-*HHRC3Q>':57!X^@I>]]7QV$
MJ4<70YO>5.M&,TIQE%%%%%<Q\J%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?F=_P4\_:F_X4
M#\#[CP9X7U+[-\3/B_!J'AS1'MIMMYH'A41)#XJ\3*8R);:?[)=IH>BS*T,R
MZGJ7]HV;R/HUR@_1;Q#X@T?PGH&M>*/$6I6VD:!X=TK4-<UO5;Q_+M-.TK2;
M6:]U"]N& )6"VM8))I" S84[4+$ _P 7_P"UG^T-K/[3GQP\6_$_43<V^C3S
MC1?!&C7+;CH/@K2I9ET2P*!GCCN[D2W&L:L(F:.36M3U)X?W+QI']%PWEGU_
M'*K5C?#81QJ3NKJI5NG2I=FFUSS3TY8\LM)Q9_3/T7O"K_B(?'=/-\UPOM>%
M^#YX;,\P52%Z&/S3G<\IRI\R<:D)5J4L;C*;C.$L)A)8:LH?7:4G\U4445^K
M'^MX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]#_LM?'[
M7?V:/C9X/^*NC_:+BQTV[_LWQ;HT#A!XA\&ZG)%%K^CL&98FN&MTCU#2WFQ#
M:ZU8Z;>.CBVV5_:1X6\3Z%XT\-:#XO\ #&I6^L>'/$^D:=KVB:G:DM;W^E:M
M:PWMC=1EMI42V\T;;) LD9RDB(ZLM?P85_0C_P $>OVI?[1TS5/V7/&6HAK[
M1TU'Q3\*9;N4[[C27D>\\4^$82Y&]]-N))/$VEP*))GL[OQ%]RVTNW2OC>+,
MK5:A',*,5[7#1Y:R2UGA[W4^K;HR;;?_ #[E)MV@C^*OI@^%/^L'#M#Q'R?#
M\V;\+45A\]A2C^\QG#DJKDL5)).4ZF38BK*K)VNLOQ6,J5*BIX2G%?N_1117
MYR?YF!1110 4444 %%%% !1110 4444 %%%% !1110 45@ZUXH\,^'$67Q%X
MBT+0(V!99-:U?3]+1E!(+*]]<6ZE<Y&X'':N%?X]? V.98)/C/\ "=)FW;87
M^(OA!96VYW;8SK(<A<-N^7C!S6T,/B*BYJ="M4C_ #0I3DO/6,6M.NHKKNOO
M/6**X/3/BE\,=;*KHWQ&\":NSDJJZ9XN\/W[,1P0HM-0E)(/''>NY1U=5=&5
MU=0RLI#*RL-RD,N05(/![]><\Q.G4INU2G.F^TXRB]-]))=U]X)I[-/TU'T4
M45 PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBJ&HZKI>CV[7FK:E8:7:)G==:C>6]E;KCKNFN9(HQCOEN*:3;22;;=DD
MKMO:R7?RW?0"_17EEQ\<O@I:2"&Z^,/PMMI2_EB.X^(/A*&0N<D($DU=6+D*
MV%V[CM-=#HGQ%^'_ (FF6W\.>.O!VOSN 4@T3Q-HFJS,&P5*QV-].[!@R[<
MYW#\-I8;$QCSSP]>,;7<I4IJ*]6XV_$5UW7WH[*BBBL!A1110 4444 %%%%
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M6:?0-?M&-GKV@7C !OM&DZI%<6ZS,D2WEJMKJ$*"VO(&;VBOYA?^"3'[4O\
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M]_KOBCQ5K.G>'O#VC6,9 DO-5UG5[FTT[3[5"RAKBZN(8E+*"_(K\!/VJ_\
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M=HX[SQS\"M:&KV*M(P0RO\.O'-[9WUG:0',TLT'Q$UFZ:'>D%A--&B3?T/\
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MMC,VE>/)A)%XQ-L&DNI+'Q];ZEJFI2+#91>,-$M?GC_LQ_9$_;G_ &:/VX_
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M%//^CP?B1_X+_!7_ ,RU?F/11_JIPO\ ]$WD'_AFR[_YF_J[\K'M*G_/R?\
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M_P"9!]EMO^?>#_OS'_\ $T?9;;_GW@_[\Q__ !-3T47?=_U_PR^X.>?\TO\
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M]ZRC3KTU[>DHVJTJ/L4*ZK1O:TU;FC^J\G\[=>C?H%%%%?GQN%%%% !1110
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M(U(UHII.$\ZQ%.&)^TI8##8"I3DEB*L64445]B?V>%%%% !1110!]Y?LU_\
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M (?0_M4?]"7\"/\ PE/'?_SS*_(RBC^PLH_Z ,/_ . _\'^KORL?\0!\&O\
MHW?#G_A-5\O^G_E^/K?^]3P[J$^K:!H6J72QI<ZEH^FZA<)"K+$D][907,BQ
M!WED6)))66,-)(ZIMW.V=U;E<QX)_P"1,\(_]BQH'_IJM*Z>OQZ22E)+^9_@
M[?DC_%_%PC#%XJ$4HPAB*\816BC&-62C%:O9)(****1SGSW^U1\5/$7P1_9]
M^)_Q4\)VNCWWB/P7H,.JZ39Z_;7MWH\UQ)JNG6++?VVGW^EWDT0ANY6"V^H6
MC>:J'?MW(WX#?\/H?VJ/^A+^!'_A*>.__GF5^V/_  4+_P"3,/C_ /\ 8GVW
M_J1:)7\;=?=<*Y;@<9@L14Q6&IUYQQ3A&4TVU'V5*7*M=%=M_-G]_P#T2O#/
M@+C7@?B+,>*^%LJSW'87BNM@L/B<?1G4J4L+'*,HKJA!QJ12IJM6K5$K/WJD
MM=[_ *Y_\/H?VJ/^A+^!'_A*>.__ )YE'_#Z']JC_H2_@1_X2GCO_P">97Y&
M45]1_864?] &'_\  ?\ @_U=^5OZI_X@#X-?]&[X<_\ ":KY?]/_ "_'UO\
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M8U-?W<L10J45/37W7-2T[#B[2B[7M).SUO9IG^O/17P'_P $Y_V]_AG_ ,%
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M-4K*GW83#J5JM1:)^Y%K=JSYG?HFM+73:OT0BJJ*$0!54!550 % & J@8
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M+?BU)97!2[T+X;0WL,D<.CK+')9ZQX^NK>YTJRN%FTW1+;6]7MM3AT;^Q?\
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MGP3_ ,B9X1_[%C0/_35:5T]<QX)_Y$SPC_V+&@?^FJTKIZ_"9_'+_%+\V?X
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M_"GQ.%BMKGXK_#/3M3\5?#B_< !]0UKP:LFH>.O"A8_>M]#_ .$_CFDWS?\
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M?^"='[)>H_ML?MA?!SX"QP73>%M9\0)XC^)NH6K21G2/AAX4VZSXTN?M4?\
MQXW6HZ;!_P ([HMTQVIXBUS1X?\ EL$K_42TO2]/T33-/T71[&UTS2=(L;33
M-+TVQ@CMK+3M.L+>*TL;&SMH56*WM+2VBCM[>&-$CAAC1%0*H%?SIX^<4/#X
M++^%,-.U3'RAF69<LM8X.A4<<%0FEHUB,5&=>VZ>#I2^&H=V"IWE*J]HWC'S
M;^)_):?-G\V7_!RC^QM_PMG]F_PE^UCX1TG[1XV_9SOQHWCA[6'==ZG\'O&6
MHV]I+<3^6K3W0\$^,9M,U*UC55AT_1O$GC#5+ATA@>OX7*_UTO'O@?PO\3O
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MWVIXF^(>N.NC>!O#WEHZW$MO?^([VP;5VM1)-8Z#;ZKJIC\BPF=/K>OXBO\
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MK-YX?\4^%]=MOLFJ:/J]A)LGMKB(EDE1AMFM;JWDFL[ZSFAO["YN;.YAF?\
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M_5\;AFVH8BA)]'9QJ4VW.C44J<_>5W[-*I&K%2CZ-=4^S_K4*_DN_P"#JO\
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ML\L<$$<DTTTB1111(TDLLLC!(XXXT#2/*\C*JJJLS,VQ/>*OUC_X)0_LM?\
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M@/\ @@G_ ,HG/V4O^ZZ?^M)_&*BC_@@G_P HG/V4O^ZZ?^M)_&*BO\]>-?\
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M_P"3,/C_ /\ 8GVW_J1:)7\;=?I'!G_(OQ7_ &&/_P!,43_3GZ$7_)NN*?\
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M2BO<IS52$9K[2O;L^J^3T"BBBO#+"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KQ_P"/_P :_!G[.'P4^*'QU^(-U]E\(?"WP;K/
MC#6 LD<5Q?C3+5WL=$T\R_(^K^(=2:ST+1[=N;K5M1L[9,O*!7L%?R-_\'-_
M[:']GZ+\-?V&_!>K 76O-8?&#XUK:3;BFC6-S<6WPS\'WPC+(1J&KVVI>-=3
MT^X$5S;_ -A^"-20/;7R;_J>"^'*O%?$N69+!35&O6]KCJL$[T,!0M4Q=3FL
MU&3IITJ+E9.O4I1^T95JGLJ<I]4K17>3T7W;OK9,_DZ^.WQE\9_M#?&3XF?'
M#XA7GVWQE\4O&6N>,M<=7D:VM;C6+V6X@TG3UD9F@TG1+(VNC:/:[MMGI=C9
MV:8CA2O****_T"H4:6&HTL/0IQI4:%*G1HTH+EA3I4H*G3IPCM&$(1C&*6B2
M1XC=VV]WJPHHHK4#]<?^"-'QV_9!_9<_:FN?VB/VL_$FM:5'\.?".H0_"/2=
M%\&:WXNDN_'GBE)]$OO$=V-*MKB"SA\,^%9-:M;6.\6.2;5/$5AJ=@Z3:.]?
MUC_\1$O_  3#_P"BD_$C_P ,_P"-?_D*O\\>BOS?BCPNX?XOS3^ULWQ><_6%
MAZ.%IT\-B\/3P]&A1YG&%*%3!U91YJDZM6;=25ZE235HVBMZ6(G2CR04;7;U
M3O=V7==$D?Z''_$1+_P3#_Z*3\2/_#/^-?\ Y"H_XB)?^"8?_12?B1_X9_QK
M_P#(5?YX]%?.?\0%X*_Z"<__ /"["?\ SO\ 7^EKI]=K=H?^ O\ ^2/]#C_B
M(E_X)A_]%)^)'_AG_&O_ ,A4?\1$O_!,/_HI/Q(_\,_XU_\ D*O\\>BC_B O
M!7_03G__ (783_YW^O\ 2U/KM;M#_P !?_R1_H<?\1$O_!,/_HI/Q(_\,_XU
M_P#D*OY=_P#@M+X0^"_Q*^*W@W]O[]EG6[;Q3\ OVNXM8_MJ\M+"YTNX\)_'
MKX?K9:7\0/#GB;0[J**^\-ZUXATBX\.^-%L]6BM[S7+S4O$.MV"7.E/;7\OX
MGUZEX:^+7B?P_P##7Q]\'YI3JWP[\?WN@>)+OP]>2LUOH?C[PE)<KX:\?>']
MPDCT_P 16NDZEKWA34IEA:/5O"/B;6]*N42\CT35=']OA[PPRO@[,Z.;<.XS
M,W6DGA<?A<?B*%7#XO+ZSC[2,?9X6@Z>(P]:-'%T)N4XS]A/#N,57=6G%3$2
MJQ<:B5MXN*LU);;O9JZ:\_*S\MHHHK]0.<*]L_9O^._C+]F+X[_"KX_> )FC
M\5?"OQEI/BJQMVG>"WU>TM9C!K?AW4)8PT@TGQ1H-QJ7AW6%C_>2:7JEXB?.
MXKQ.BL<10HXJA7PN(IQK8?$T:E"O2FKPJT:T)4ZM.:TO&<)2C)75TV@5TTT[
M-:JW=--/\#_6S^#'Q:\&_'GX3?#GXS_#V_\ [2\%_$_P=H/C7PY=/L$ZZ=KV
MGPWT=I?11NXM=4TYY9-.U:R9O,L=2M;NSG"S0.H]-K^4#_@V5_;2_P"$E\!_
M$7]B#QGJV_5_AY)??%7X-+>3_/<>"==U**+X@^%K)7*JJ^'?%VHV7BJUMX_/
MNKL>-?$-Q\EEH_R?U?U_GWQAP[6X5XCS/):BDZ>&KN>#JRWKX&LO:X2K>R3D
MZ,HPJ\MXQKPJP3?(SVZ-15:<9]6K-=I+1_*^J\K!1117S)J%%%% !1110 44
M44 %?QY_\'6O_(0_84_Z\_VE?_1_P%K^PROX\_\ @ZU_Y"'["G_7G^TK_P"C
M_@+7Z;X._P#)QN'O3-__ %1YD<^*_P!WJ?\ ;G_I<3^0NBBBO[C/'"BBB@#_
M $Z_^"2/_*-;]C7_ +(IX>_]'WU?HK7YU?\ !)'_ )1K?L:_]D4\/?\ H^^K
M]%:_SJXF_P"2CX@_['>:_P#J?B#W:?\ #I_X(_\ I*"BBBO$+"OYLO\ @MG_
M ,$:K3]J'2-<_:I_9C\.06G[2&@Z<;SX@> ])@C@B^.FB:; %^V:?;Q;(_\
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MX;@,^J^)?$U^EE9HQ5V@L+*'#WFKZS?LC0Z7H6DVM]K.K712STVPO+ITA?\
MA&_X*U?\%M/''[;TNK? WX#KKGPV_9:M;S9J9N7.G^-?C3-9S!K>]\8I:S.-
M&\&03QK=:-X'AN)FNIEAUCQ7/<WZ:;I'AO[?@G@/.>-<=&E@Z<L-EM*I%8_-
MJM.3PV'A>+E3I-V6(Q<H/]WAJ;O>2E5G1I7J+&M7A1C=M.3^&-]6^E^R\W\K
MO0]6_P""B/\ P7O^-OC']K;PEKO[%WCS4?!_P2^ .LW\'ALS03MHOQYU:<_8
M?$7B#Q]X:N?LPU3P-J5G')I/@_P_J"PZIINFO/XMANM!\3ZK;0^'_P"EW_@F
M?_P5<^"'_!1/P4MCI[VGP[_:#\-Z7'=?$'X,ZEJ"RW1BB\N&Y\6_#^]G$4GB
MKP7-<NJSR1QKK/AFYFAL/$-G"EUI&JZW_FJUV'P]^(?CGX3^-?#7Q'^&OBO7
M/!'COP?JEOK?ACQ5X<OY],UG1]2MB=EQ:7=NRL%DC>2WNK>3S+2]LYIK.\AG
ML[F:)_Z>X@\'N&<UR#!Y5EU&.68_*\.Z67YI&$95JTKRJ5(YGRJ+Q<,16E.I
M.?NU,/.I*6&<*?-0J>=#%58S<I/GC)^]![):+W/Y;);=>NNI_KH45_/5_P $
MEO\ @N%X&_;%M_#_ ,!?VD+O0_AS^U"D-OINAZMF#2/!'QQDB01I/X?#NEKX
M=^(-P%W:AX)9H[+6;AOMO@QW2YG\,:!_0K7\B9_P]FW#.95LKSC"SPN)I>]%
M_%0Q-%MJ&(PM9)1K4*EGRSC9QDI4ZD8583A'U*=2%6*E!W7W-/LUT84445XI
M84444 %%%% !1110!Y_\5?B7X0^#'PT\>_%OX@:FFC>"OAMX1U[QKXHU)]K-
M:Z+X<TVXU2_^S1,R&YO9H;9H+"SC/G7U[);V<"/-.B-_E>_M2_M">+_VK/VA
MOBW^T+XY=UU_XH^,=2\0_P!GF=KB+0=$!2P\+^%;.9PK/I_A3PS9Z3X=T^1E
M\R2STN%YMTSL[_UR_P#!S'^V@/ _PG\ _L5^#-5$?B3XPRVGQ%^+,=K/MFL?
MAEX7U9AX2T*\12&6/QCXXTV35?E99%M_ #P2HUMJJA_XG*_K7P)X5>7Y+B>)
ML53Y<7G4O88+F7O4\KPU362NDX_6\7"4FFK2I8;#5(MJ1Y>,J<TU33TAO_B=
MG]Z7W-L****_>SC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z4_8^_:
M4\5?LA?M*_"#]HGPAYT^H?#7Q;9ZGJFDPR^0/$GA*]272?&?A6:0D(D7B3PM
M?ZMI FEW?99+R&\3]_;1NG^IU\//'OA3XJ> O!GQ,\":M!KO@OX@>%M!\9^%
M-9MC^YU3P_XDTVVU?2;Q1UC,]E=PR20OB2&1GAF5)$=:_P C&O[A/^#:7]M#
M_A9?P+\:?L<^,M6$_C#X#33>,?AJEY/ONM1^$/BO52VJZ;;AV>:9? GC?4)5
MGDD98[?2_&WAS2K2-;;3<)^ ^._"OU_*,)Q/A:;EB<G:PV/<8WE4RW$5$J=2
M32;:P>+FFHJT53Q>(J2]V!VX*IRR=-O2>L=/M+=?-:ZWV/Z?****_DT],***
M* "BBB@ HHHH *_CS_X.M?\ D(?L*?\ 7G^TK_Z/^ M?V&5_'G_P=:_\A#]A
M3_KS_:5_]'_ 6OTWP=_Y.-P]Z9O_ .J/,CGQ7^[U/^W/_2XG\A=%%%?W&>.%
M%%% '^G7_P $D?\ E&M^QK_V13P]_P"C[ZOT5K\ZO^"2/_*-;]C7_LBGA[_T
M??5^BM?YU<3?\E'Q!_V.\U_]3\0>[3_AT_\ !'_TE!1117B%A1110 5_(W_P
M7+_X(P_VXOB_]MC]DGPG_P 3Q%OO$GQ_^#WAZT_Y#48#W>K?%;P)I5JF?[:C
M59K[QYX<LX\:S&)_%6F0C6$UJ'6/ZY**^DX5XIS3A#-Z.;974UC:GBL+-R^K
MX["N2=3#5XK[+MS4ZB3G1JJ-6#4HV>=6G&K%QEZI]4^Z_K4_Q_Z*_K,_X+D_
M\$8/^$.D\6_MJ?LD>$\>#Y6O?$?QZ^#_ (=LOE\)2NSW6J_%'P-I=HOR^%96
M,M]XV\.V<)7PO(T_B3384\,MJT/AK^3.O[HX5XIROB[*:.;975O"5H8G#3<?
MK&!Q*BG4PV(BGI*-U*$U[E:FXU:;<)(\>I3E2FXR7FGTDNZ_*SU3"BBBOI#,
M**** "BBB@#_ $@/^""?_*)S]E+_ +KI_P"M)_&*BC_@@G_RB<_92_[KI_ZT
MG\8J*_SUXU_Y++BW_LIL^_\ 5KBSVZ'\"C_UZI_^D1/V HHHKYDU"ODO]M+]
MFS3OVHO@1XF\!)#;1>,=-!\2_#K5)]D9T_QAI=O-]CM9;EN(=.U^"2XT'5';
M?%#:ZA_:'E275A;%/K2BM:%>IAJU*O1DX5:,XU(27246FDUUB]I1>DHMIZ,]
M?(,\S/AG.\JXAR;$2PF:9-C</F&!KQNU"OAZD:D54BFO:4:BBZ5>C)\E>C.I
M2J)PG)/^![4]-U#1M2U#1]6LKK3M5TJ]N]-U/3[R![>\L-1L9Y+2\LKJ"0"2
M"YM;F*2&:&15DCDCD1_G3FA7[0_\%=_V6O\ A!?'MA^T;X0T[R_"OQ*O5TKQ
MY#:Q8@TCQ_%;N]OJ\BQ@)#;^,-.MI)IFVE7U[2]2N;F;[5K=O')^+U?LN78R
MGC\'1Q5*R52*YX7O[.I%)5*;ZWC)63=KQY9)-.[_ -N?#?CG+/$;@W).+LK:
MA3S/"KZWA>=3GE^94'[+,,!5=E)O#8J-2-.<XQ=>@Z.)BO9UH-E%%%=Q]P%%
M%% !1110 4444 %%%% ']Y/@G_D3/"/_ &+&@?\ IJM*Z>N8\$_\B9X1_P"Q
M8T#_ --5I73U^$S^.7^*7YL_P!QW^^XS_L*Q'_IZ84445)RGQG_P4+_Y,P^/
M_P#V)]M_ZD6B5_&W7]DG_!0O_DS#X_\ _8GVW_J1:)7\;=?I'!G_ "+\5_V&
M/_TQ1/\ 3GZ$7_)NN*?^RUK_ /JBR0****^P/[/"BBB@ HHHH **** "BBKE
ME97FI7MIIVG6MQ?:AJ%U;V5A96D,EQ=WEY=2QP6MK;00JTMQ<7$TD<,,,:M)
M)(R(B%WI2=E?\6[)=VWY+5]+)Z]YE*,(N4FHQBG*4I-1C&*U;<G9))7;;:6G
M:[7W3_P3Q_9=?]IGX\Z9!KM@UQ\,?AW]B\6_$*21";:_ACN6_L+PC(V-I?Q3
MJ%O)#=0[HI&T&QUZ:%TN88=_]>R(D:+'&J)&B*L<:J BJH"JBJN%554;5"C:
M .>*^0/V'OV:+/\ 9=^ _A[P9=6]N?'6O;/%7Q(U"(QRM-XIU&W@#:3%<KN\
MW3O#5FD&AV9C?R+B6TO-5CCAFU.YS]B5^29_F;S+'2<)-X;#WI8=7=I)/WZV
MK>M62NGO[-4T]4S_ !T^D5XIOQ0X^Q57 8AU.&.''6R?AR,9-TL13A47U[.$
MOAYLVQ%-5*4[1E_9]' 4YQC4IS;****\,_! HHHH *S-9UC2_#NCZKX@US4+
M32=$T'3+_6-9U6_F2VL=,TK3+66^U#4+VXD*QV]I96D$UQ<32,L<,,;R,0J&
MM.OY]/\ @XE_;-_X9\_8^C^ OA/5?LGQ*_:GN=0\(W"VTVR]TKX1:*MI<?$>
M_;8S&-/$GVS1_ 2PW,:QZCI/B+Q*]M*)M*?;[7#F28GB3/,LR3"W53,,5"C*
M:5_8T%>IB<0UUCA\/"K6FMW&#2ULG%2:IPE-[17WO9+U;LC^.+_@HA^UIJG[
M;/[7GQ@^/MS+=KX;UW7WT'X:Z7=EXVT/X8>%]VD>"K$VKY%E=W>EP+K^N6T?
M[MO$FM:Q<_\ +R]>O_LC?\%>_P!NS]C6/3=$^'OQ<N_&OPXTWR8HOA1\78[G
MQ[X'@LX2HCT_1/ME]:^*?!UDBAL67@OQ)X?LFE=YKFVF?%?F117]]SX<R2ME
M.&R/$Y;A,7E>$P]'"X?"8JA3KTZ=+#THT:;CSQ;C54(+]]#EJ*7OQDI:GB<\
MU-S4I1FVVY)V;N[N]K)KLG=:+1G]Q_[,?_!S?^S-X\CL-%_:@^&'C3X"^(7$
M4-WXN\)";XH_#EV7"SWUS!IUI8?$#1$E;]Y#IEGX7\8&&/>DFL3.BM-^\WP-
M_:Y_9A_:6L8KWX#?'GX7?%%G@6YETGPMXNTF\\3:?$4\PC6/"4MQ!XIT201_
MO&AUC1[&=4^=D"U_E%58M;NZL+FWOK&YN+.\M)H[BUN[6:2WN;:>)@\4]O/"
MR2PS1N$:*2-ED#+O1Z_)L]\!N&<?*=7)L9C<CJR;:I7_ +1P,;M;4<14ABDV
M]/\ ?G%+2$-+/JAC:D=)I37?X9?-K3_R4_U^**_R]_A)_P %2?\ @H9\$([6
MW^'W[7/QE@L+/8MGI'B[Q(/B;H-G''M*06>@?$RV\7Z+:6PQ_P >EO8QV[?/
M\GSO7Z$^ _\ @Y0_X*->$HX8O$D'P$^*(3:);CQE\,]1TJ]F4 !VW_#OQ=X%
MLHIF&2KC3VA5N?*=/DK\UQ_@'Q;AY-X''Y-F%._NIUL1A*[\W3JX>5&/RQ,O
M\]UCJ3^*,X^=DU]]T_O2\C^_^BOXIO#O_!T_\=+5(QXM_90^$VMR#_6MX=\=
M^,/"Z/W/EIJ=AXO,63]W=)+BO4K+_@ZUN51%U#]A.&:3(#RV7[2\ELF.<E+>
M?X!W3$_[+7?XU\]5\&O$2FVHY'2K)?:I9ME"3]%6QM*7X+RN:+%T']MKUC+]
M$S^P>BOY#?\ B*TTSRL_\,+7_G;\"/\ X:2M_+*8^]YI^!(8-NPNWR=NWY]_
M\%>7>,?^#J7XKWT$J^ /V/OA[X9NB'\B;QC\5?$GCF"/(^0RVVB^$/AY),%/
MWE6ZMS(O]RHI>#GB)4ERRR&%%72<ZN:Y/RJ]MU3Q]2?5;0;\@>+H+[=_2,__
M )'^ON/[0Z_,O_@H7_P5._9M_P""??@W4_\ A,/$%AXW^-UYIKS>"/@3X:U2
MTF\7:M>7$&[3=1\6&$7/_""^#WD9)I_$&N0K-?VL=RGAG3/$.H0M85_&-\?O
M^"]/_!2/X\V=]H\/Q;TKX)>'M01X[G1_@-X<7P1=[&!7_1O&NIWWB3XD:>RJ
MS#.F^-+/=N._>40I^/FKZMJVO:G?ZUKNIZAK6LZM=37VJ:MJU[<ZCJ>HWMR[
M2W%Y?W]Y)-=7EU/(S2S7%Q-)-)(V]W=Z_1.&/ /$+$4<5Q9F%!8>G*,Y99ED
MZE2I7]Z+]EB,;.%&-&#:Y:D</"K.4&U3Q%*5I+"IC59JE%WVYI:?<K._J_N9
MZO\ M#?'WXD_M0_&CX@_'GXMZP-:\>_$?7IM;UB:%9(M/T^ 1Q66DZ!HEK++
M.]CH'AS2+:QT/0[%IYI+72]/MH9IKF9'F?QBBBOZ8P^'HX6A1PV&I0H8?#TJ
M=&A1IQ4*=&C2A&G2I4X))1A"$8QC%:))):'GW;;;=VVVWW;U;^\****V W/"
M_AK6_&?B7P]X/\,Z?/JWB3Q7KND^&O#^E6J[[G4];UZ_M]+TK3[=,?-/>W]U
M;V\*_P 4DB>U?ZPG[/WPFTWX#_ KX.?!32'BFT[X3?##P+\/+>ZA0HE__P (
MAX:TW0I=28,%=IM2GL9+^XDD DFGN))929)),_PS_P#!O#^Q9>?M!_M?P?M!
M>*-):;X6?LM?9/%D=Q=0,;+6OB]J4=Q%\/-(M7*JLTWAEXK[Q]=2V\K2:;?Z
M%X;AO(?(UR'?_?Q7\H>/G$-/&YMEG#N'J<T<II3QF.Y6FEC,=&G[&C);J=#"
MTU4>WNXRS]Y-+T<#3:C*H_MM*/HM_DY=];KH%%%%?S\=X4444 %%%% !1110
M!^-W_!9K_@FS:?M^_L]?VMX#T^TA_:1^#%MJOB'X4WI$%M+XRTV6%9_$7PKU
M.]D9(Q;^)%M8;KPU<7DB0:3XLM+#?<V&DZKX@EF_SG]5TK4]"U34=$UO3K[2
M-9T>_O-)U?2=3M)[#4M+U/3[B2TO].U&QNHXKFROK*ZAFM;RUN(HKB"XC>&9
M$='2O]?&OY6/^"['_!'6Z^+<?B/]M7]EGPN]U\3["SDU/XZ_"[0;3=<?$/3-
M/MLS?$?PAIULF^X\>Z990?\ %4:':1M-XTT^%=5TV%_%MG>6OBW^@/!SQ&IY
M14I\*9YB%#+<15;RG&5I6IX'$U9ISPE:3:5/"8FHW.E4TC0Q4Y>T7L\1*I0X
M<7AW/]Y!7DE:<?YHZ*Z75I?>MDWH_P"*:B@@@D$8(X(/!!'8]?7\/?-%?U@>
M:%%%% &[X8\4>)O!/B#1_%O@WQ#KGA/Q5X>OH-5T'Q+X:U6_T/7]%U*V;?;:
MCI.KZ9-:ZAIU[ _S0W5G<0S1MRCBOZ2_V,/^#E3X_?">UTGP7^UMX+M_VA_"
M-HD%I'\0O#\MAX2^,&GV<8">;J<?D1^#_'LD$*1QPK>6_A'6+J1IKS6/%6IW
M,E?S+T5\_G_"N0<48=8;/,LP^.44U2K2BZ>*P]W=O#XJDX8BCJDY1A44)M+V
MD9I6*A4J4W>$VN_5/;=.ZZ=NNEM;_P"EO^SU_P %F_\ @G/^T;;V,?A[]HKP
MO\.O$EXL0D\&?&YE^%&N6EU,!Y=@NI>)IH/!FLWKN?+6'PQXLUY7E/DQR.[(
ME?IKHVMZ+XCTVVUGP]K&EZ]I%['YEGJNC:A::IIMY&>DEM?6,L]K/&?[T,CK
M[U_D)UUWA+Q_X\\ W;7_ (%\;>+O!5\Y5GO?"7B36?#EVS(/D+7&CWMG,Q7'
MRL7^7TQ7XKFGT>\LJSE/)^(,9@XMMQH8_"4L>E?[*KT:N"E&"V3E2JRLO>E)
MWD=<<=)64X1D^\6X]5T:EW[KYG^NE17^539_MV?MOZ=;K::?^V1^U586J#"6
MUG^T-\7+6W0<?*L,'B](U' ^ZO\ #WXKAO%W[3G[2?C^WEM/'G[0OQQ\;VLZ
M[)K?Q=\6?'WB2"9 ,;)8=9U^]CD7!Y5E9>>]>'#Z/.9N:53B7 PIMZRA@*]2
M:5U?]W+$TTVE=V]HD[64NUO'Q2TI2O;9R7EV3;WZ(_T[_C;^VK^R5^SC;W<W
MQN_:*^$?P[NK(2&70=:\::/+XNE,8)=+'P5IMQ?>+M3E0*=T.G:+=2JQ5"FY
MTS^ O[6O_!SC\%O"%KJ7AS]CKX8:W\7O$NR:"S^(_P 3;:^\#_#:RFY\C4+'
MPHCP^/O%<!Q^\T[5#\.95WJZ7<VQH6_B9)SR3UY)-%?;9%X$<+9=4A7S;%8W
M/:L&G[*I; 8%M6?O8?#SGB):J_++&NG)>[.G--IY3QE62M%1@N_Q/IU>GH[7
M7R/JC]JO]M7]I?\ ;3\:?\)M^T1\3];\;7%I+<-X>\-*ZZ3X&\'07) >T\(^
M#M.$&AZ,K1I#;76H1VLFM:M';PS:WJNI7*"YKY7HHK]GPF#PF PU+!X'#4,'
MA:$5"CAL-2A0H4H+[,*5.,815]79*[;;NVV<C;;NVVWNWN_ON%%%%=($UO<7
M%I<07=I/-;75M-%<6US;RO#<V]S"ZO#/!,C+)%-%(BR1R1LLD<BHZ/OK^P#_
M ()&_P#!?99O^$8_9I_;S\5!9?\ 1-"^'?[2VMW "2_=M].\/_&J]E8!)#^[
MMK/XG3-MD_<OX\".+_QA-_'S7V9^PQ^PY\9_V^/C?I'P=^$FF-;V,36NJ?$3
MXA7]I/+X6^&GA!KCR;KQ#KLT;1+/>3!)K?P[X?AGCU#Q)JJ_8[9[6VAU+4K#
MXWCCA[AO/<BQ4>)/98;"8.E4Q$,T;C3Q&6-17-7H5FI/6R4\.XSAB7RPE2G-
M0MI2J5(3C[.[<FER])>3_3JKO;5K_4N@G@NH(KFVEBN+>XBCFM[B&1)89X94
M$D4T,L9:.2*2-EDCDC9E96#*3GF:O$OV</@3X5_9D^!?PP^ ?@C4O$>L>%_A
M;X4L/"VE:KXMUF\UWQ!J,=J9)KB]O[Z\ED\O[3>3W$UKI=BMKHNB6;6^BZ#8
M:;HFGZ?86WMM?P-7C1A7KPP]6=?#PK5(T*]2DJ$Z]&,VJ56=%3J>QE4@E*5+
MVE3D;<>>=N9^VKV5U9V5TG=)]5>RO;O97[(****R&%%%% !7,^,O%_AOX?>$
M/%'CSQCJ]KH/A'P5X=UKQ7XHUR^<I9Z/X>\.Z;<ZOK.J73@$K;V&G6=Q=3,J
MLWEQL5&<9Z:OYJ?^#DK]M#_A4'[-_AG]D_P=JPMO'?[1]R=2\;):S;;S2?@U
MX4U"&:\AF\LI-;?\)WXL@L=%MY=S6^H:'H/C339XV6;CW^%\@Q'$^?Y9DF&Y
ME+&XB,*U6*O]7PD$ZN+Q#NFOW.'A4G%/2<U&&\DC.K45.$IO[*T6UV]$OFVD
M?R _MN_M1>)/VROVI/C#^T/XC^U6Z>//%,[>%=&NI [>&? .CI'HW@7PV KM
M LVD^&+'38=2DM5CAOM8?4M5V>=?S;OE.BBO]",'A,/@,)AL#A*<:.%P>'HX
M7#4H_#2H4*<:5*"ZVC"*5W=O=L\1MMMMW;=V_,****Z1'T_^QU^R9\3OVV_C
M]X/_ &>/A*^C6?BGQ7;ZYJ$VO^))-0@\,>&=$\/:1=ZOJFN>(KO2]/U6^M=/
MC2VCT^V:WL;B2ZU;4--L(4\Z\2OW$_XA<OVS?^B\_LQ?^#7XJ_\ SL*_0;_@
MV5_8^_X0?X-?$C]LKQ5I?E>(?C-?S_#?X83W,.)K;X9>#M4W>*]6L96 8V_B
M[Q_9+I=Q&VXK_P *[MIH<1W9W_U+U_,/B%XO9]E/%&.RGAS$82G@LL5/"8B=
M;"T<3*MF$$Y8MJ<]8QHSFL(X+15*%22;4HV]"AA83IJ=1.\M4D[6CTO:^N[]
M&C^&+_B%R_;-_P"B\_LQ?^#7XJ__ #L*/^(7+]LW_HO/[,7_ (-?BK_\["O[
MG:*^)_XC=Q]_T&Y?_P"&S#?Y?U=^5MOJ='M+_P "9_#%_P 0N7[9O_1>?V8O
M_!K\5?\ YV%'_$+E^V;_ -%Y_9B_\&OQ5_\ G85_<[11_P 1NX^_Z#<O_P##
M9AO\OZN_*Q]3H]I?^!,_AB_XA<OVS?\ HO/[,7_@U^*O_P ["C_B%R_;-_Z+
MS^S%_P"#7XJ__.PK^YVBC_B-W'W_ $&Y?_X;,-_E_5WY6/J='M+_ ,"9_#%_
MQ"Y?MF_]%Y_9B_\ !K\5?_G84?\ $+E^V;_T7G]F+_P:_%7_ .=A7]SM%'_$
M;N/O^@W+_P#PV8;_ "_J[\K'U.CVE_X$S^&+_B%R_;-_Z+S^S%_X-?BK_P#.
MPK\'_P!JG]FKXB_L@_'OXB?L[_%1-/;QE\.M5MK*[U'1GO)= U[3=3TVRUK0
MO$.@W&H6>GWEQI&MZ-J-CJ%HUQ9VMQ&LSVUS##>PSPI_J^U_)7_P<Z?L=_VQ
MX4^%7[;?A'2@U]X1EMO@Y\89;6'YW\,ZQ>7>H_#?Q+>[%1%BTCQ)=:UX5O+R
M9IKBZD\6>%;!-EM8)L^[\.?%W/,YXGPN3\25\)4PN94ZF'PE2EA:6&E2S!<L
M\,I2IVYXU^2>'C!IMUZM%IQ2:>&(PL(4W.FG>+3DF[^[LW\M&_*Y_&G1117]
M,G %?87[!'[5NN_L5_M8?!_]H323=SZ5X2\1Q6/CO1K1SO\ $GPW\0J=&\<Z
M((6989[J;0;JZO-&^U>9#:^(K'1]2V;[-*^/:*Y<;@\/F.#Q6 Q=.-;"XW#U
ML+B:4MJE"O3E3JPOTYH2:YEJMTT[,:;BU*+LXM-/S33/]>3PSXDT+QEX;\/^
M+_"VJ6FN>&?%6B:5XD\.ZUI\@FL-8T+7+"WU/2-4LIA@2VFH:?=6]W;2=)(9
M4<8K<K^<;_@W#_;1_P"%W_LN:Q^S%XQU;[1\0OV8[BWM_#2W4VZ\UCX,>)KF
MXF\,O$9&\RY_X0K7%U3PI<+"AM]+T&3P3:N0]R@/]'-?Y[<39#B.&<]S/),3
MS.> Q,J=.HU95\-)*IA<1%*R2KX>=.I9+W7)P>L6CVZ515:<9K[2U79[-?)W
M04445X1H%%%% !1110 5_'G_ ,'6O_(0_84_Z\_VE?\ T?\  6O[#*_CS_X.
MM?\ D(?L*?\ 7G^TK_Z/^ M?IO@[_P G&X>],W_]4>9'/BO]WJ?]N?\ I<3^
M0NBBBO[C/'"BBB@#_3K_ ."2/_*-;]C7_LBGA[_T??5^BM?G5_P21_Y1K?L:
M_P#9%/#W_H^^K]%:_P ZN)O^2CX@_P"QWFO_ *GX@]VG_#I_X(_^DH****\0
ML**** "BBB@".2-)D>*5$DBD1HY(Y%#HZ."KHZ,"KHZG:RME64GCU_B#_P""
MWW_!&63X%7GB7]L']E/PNS_!+4;J?5_B_P#"[0[0L?A!J%W(9+KQCX6T^V4E
M/AA?7$C2:MI=O%M^']U+YUJB>"YO)\*_W 53OK&RU2RO--U*SM=0T_4+6XL=
M0T^^MXKNROK*[B>"ZL[VUG22"YM;F"1X;BWF22&:&1XY$='Y^LX.XPS3@S-Z
M>99?)U*%3EI9A@)S<:&.PW,FX3TDH5J:<I8?$*,I4:C?NSISJTJF56E&M'EE
MHU?EEUB]->EUIJKV:T[-?Y!=%?T;_P#!;#_@C=>?LGZUK7[4'[-6@75]^S-X
MCU/[1XS\':=%-<W'P(U_5;I418T422O\+]8OIUM]#OVW?\(KJ$\/AO4G2VFT
M&YO/YR*_NCAWB+*^*,JP^;Y3757#5URSA*RKX6O%)U<+B::<O9UZ+DE*-W&4
M7&K2E.C4IU)>/.$J<G"2LU]S7=:+3^M] HHHKW" HHHH _T@/^""?_*)S]E+
M_NNG_K2?QBHH_P"""?\ RB<_92_[KI_ZTG\8J*_SUXU_Y++BW_LIL^_]6N+/
M;H?P*/\ UZI_^D1/V HHHKYDU"BBB@#R_P",OPI\+?'#X8^,_A7XQ@\W0?&.
MBW&FS3HBR7.F7@*W&E:W8B3*#4=#U2"SU6Q,G[O[79PI,DD)=&_BE^+/PQ\4
M?!GXD>,?A?XSM?LOB+P9K=SH]\55Q;WL496?3]6L3(%>33=9TZ:UU?39F56G
ML;RV=T1WV5_=57XE_P#!7W]EK_A+O!VF_M*^#]-W^(O =M!H?Q&@M8MTNI^"
M9KDC2]?E2,;I;GPKJ5TUO>2>6TK:%JC7-S,EGX>1#]5PKF?U3%_4ZLDJ&+DE
M%R=HPQ.B@_)54E3=KMR5*[Y8RO\ UU]$CQ6_U/XOGP1F^)Y.'^,\12IX.565
MJ67\2J*HX*HKNT(9M34<MK63<\2LL;E"E2J,_G#HHHK]./\ 4X**** "BBB@
M HHHH **** /[R?!/_(F>$?^Q8T#_P!-5I73US'@G_D3/"/_ &+&@?\ IJM*
MZ>OPF?QR_P 4OS9_@#CO]]QG_85B/_3TPHHHJ3E/C/\ X*%_\F8?'_\ [$^V
M_P#4BT2OXVZ_LD_X*%_\F8?'_P#[$^V_]2+1*_C;K](X,_Y%^*_[#'_Z8HG^
MG/T(O^3=<4_]EK7_ /5%D@4445]@?V>%%%% !1110 4444 %?L=_P2/_ &6?
M^%C?$F\_:"\7:=YO@WX57R6O@Z*ZCW6^M?$AX(YXKR/>&66'P583PZIQL:/7
M=0T&XAD?[#<I7Y7?##X<^*/B[\0?"/PT\&61OO$WC36[/1-+A;?Y,3W#EKC4
M+MT5V@T[2[-+C4M3N]K+:Z?9W-R_R0O7]K/P.^$'ACX"_"GP5\*/",(72?".
MD0V3WCQK%<ZQJLA:ZUK7KX(6'VW6]5GN]2N%4F*!KG[-#LMHH8U^4XIS183!
MK"TI)8C&1DG:7O4\/HJDGU3G=THNVW.TTXG\F?2Q\5O]2^#%PCE&)]GQ'QI1
MKX:I*E.U7+^'$_99EBKQ?-3GF+;RO"RDH\].>85J,U4PB/6J***_,C_*H***
M* "BBB@".22."-Y972**)&DEED8)''&@+.[NQ"HB*"S,Q"JH_+_,K_X*S?MD
MR?MN?ML?$_XFZ1J3WWPR\*7(^%WP<1)"]H?AYX,O+ZWM==M%. $\;:[<ZYXV
M_>*LT,7B"'3YODLTV?Z.G[0GPKU+XX_ [XK_  =TKQUK/PRO?B?X$\1^!4\>
M>'K.UU#6O#,'B73IM*O=0TZTO)((I9S97-S;9CNK&\C29YK"_L+Y+:\M_P#/
MW_;/_P""&7[</[(SZMXCTGP>W[0GPEL#-<+\1/@]87VKZGIVFQ[G^T>+OASB
M?Q?X?:&!9+G4+S3[?Q+X7TR%=]SXGSFOWKP*K<-8+-<QQ>:9G@\+G56E3P.4
MX;%R=!2H5)1J8JK1KU8QPTL16G&C1I48U5B.6%91A*-73BQJJ2C%1BW!.\FM
M=;I*ZO>RU=]>CZ:_C712LK(S(ZE64LK*RE65E8C:P."""/F7\,]Z2OZV/,"B
MBB@ HHHH **** "BBB@ HHHH **** "O;OV<_P!GCXJ?M4_&3P3\"_@UX=F\
M2>._'.IQV-C#^]BTW2-/C_?:MXE\0WR1RKI7AOP_IZS:IK6I212?9[*W=(8;
MF\GM;:;K_P!E#]CS]H#]M3XGV/PI^ '@:]\5:U(UM/X@UV<26/@[P-HT\WE2
M>(_&WB1XI+/0M(A59&C5A<:IJTT/V#0=-U;57MK";_0J_P"":'_!,+X._P#!
M.7X:3:;X?DA\<?&SQG96B?%/XP7MBMM>ZRT#+<Q^%_"MG+)/)X<\#:9=_O+?
M34FDOM9O8X]6U^ZN;B'3;;2OS7Q"\1LMX+P52A3G2Q?$&(I/ZEERESJBYJT<
M7CU!WI8:%^:%.3A5Q37)22@JM:CO0H2K23U4$_>EWL]8KN_P2=^Q[[^PW^Q[
M\/?V%_V;_ O[/WP]"WRZ%"^K^-?%CVJ6FH>/?B#J\5L_BGQAJ42O*\9OYX(;
M'2;&2YNFT;PYINB:$ES<PZ8DS_7E%%?Q%C,9BLPQ>)QV-KSQ.+QE>IB,37J.
M\ZM:K)SJ3=DDKR;:BDHQ6D4HI)>PDHI)*R2LDNB04445S#"BBB@ HHHH ***
M* "BBB@#^6+_ (+"?\$)+;XQ7/BC]J']BOP_I^D_%2Y-]KWQ/^!NGI;Z;I'Q
M+N6+75_XJ^'JYAL=&\?W+>9<:QX;?[/I/C6X9[_3WL/%;W4/BS^*[6=&UCP[
MJVIZ!X@TK4M"UW1+Z[TK6=%UFQNM,U;2-5L)WM;[3=3TV]B@O+"_LKF&2WN[
M.ZAAN+>:-X9D5T=*_P!>ZOR#_P""D/\ P1S_ &<_^"@-A?>,UBB^$/[1D%@(
M=)^,7AK3(94\0FT@$5CI?Q.\.1/90>,=.CB2*TM]66XL/%FDV\-I#9ZS-I-F
MVAW/[]X=>,E7)X4,EXJG6Q664U&EA,T2E6Q>!IJT8TL5#6>*PE.*M"<.;$X>
M*Y(PQ%/V<*7#7PG,W.E92=KQVB]KM=$[?)O71MW_ ,WNBOMW]LW_ ()Y?M3_
M +"/BU] ^/'P]N[3PY=WLEKX6^*?AH76N_"[QB/WC1_V)XJ2TMX[34)(8I)V
M\-^(+71?%%K"/M-SHD-L\,T_Q%7]3X''X+,\+1QN7XJAC<)7BITL1AJL*U*:
M:UM.#:YHOW9QOS0DG&24DTO.:<6U).+6Z:LU_7EH%%%%=8@HHHH **** "BB
MB@ HHHH **T-)TC5=?U33]$T+3-0UK6M7O+;3=*TC2;*YU'5-3U"[E6"TL=/
MT^SCFN[Z[NIWCAM[6WADFFF9$@1W>OZ<?^"<_P#P;H_%#XK3Z'\5?VXSK'P?
M^&V^UU+3_@I83);?%GQE;@I.D/C"Z3S8_AEHMTI2.ZT]OM'CR2/[99RV'@R\
M2SU4_/<1<59'PK@GCL[QU/"Q:?L,.G[3&8N:2_=87#1_>59WDDY6C2IJ2G5J
M4X-R5TZ<ZLN6"OW?1:VNWTM_PUWH?D7_ ,$^/^":O[0'_!0[XBCP]\-=,;PS
M\,] O[6+XE?&C7[&X;P?X+M) L\MC9[6MV\4^,KFT;S-)\(Z5<1W4S36USK%
MYH.B//K=M_HA?L;?L8? []ACX-Z3\&O@=X>-AI\317_BOQ9J8M[KQA\0?$Y@
M2"\\4^+]5AA@%[?SA/+L[.WBM]*T2Q$6F:/8V5C"L->W_"SX4?#?X(^!/#WP
MP^$G@KP]\/? 'A6R6PT#PMX8TZ'3=+L( 2\LICC!EN[^\G9[O4M4OI+K4M4O
MYI]0U*\NKVXFF?T*OXZX_P#$K-.-J_U>*GE^14*BEALNC.\ZTH74<3CYQLJU
M?K"E']QAT^6FISYZ]7U*&'C15_BFUK+MW4;[+SW?4****_-3I"BBB@ HHHH
MS=8U?2_#^DZIKVMZA::3HNB:=>ZOK&JZC.EM8:9I>FVTM[J&H7MS*RPV]I96
MD,UQ<SR.L<,,;R.P5#7^7C_P49_:YU3]MW]K_P"+GQYGFNQX5U36F\,_"_2[
ML21-H?PL\*M)I?@VT^RR\V5WJ5DDGB;7+5?W2^)->UAT_P!=7]B7_!Q+^VA_
MPSW^R'%\ ?".K?9/B9^U-/J'A2Z%K,%O=(^$&C"TE^(M_)L+&%?$YO=)\!QP
MW,:1ZEI&O^)VLYOM.DN$_@-K^I_ 3A7ZM@<;Q9BJ=JV8<^799S+6.#H5$\97
MA=6MB,53C1B_B2PE3[%17\W&U+RC23TC[TO\7V>O17>W5=@HHHK^B3A"O7/@
M'\&/%_[17QJ^%WP,\!6_G^+?BIXVT#P5H[-#++;V#ZS>Q6]UK-^L>'32]!L#
M=:UK%QPMKI>GWER[HD+N?(Z_JT_X-C?V/O\ A*/B5\4?VT_%>E^9H_PRM;GX
M3?">>Y@S'+X\\3Z;#=^/==LI" T=UX;\$WNG^'TD1FAN+?X@ZDG^NM/D^8XR
MXAI<+<-YIG4W%U<+AW'!TY;5<=7:HX.GRW3E%UYPE52U5&-25FHM%TZ?M:D(
M*^KU:Z133E^"LO-I']?WP7^$OA#X#_"3X;_!CP#9_8/!GPO\%^'O!'AZ J@N
M)-/\/:;;Z='>WSQJ@N-3U)X9-0U2\8&6]U*ZNKV=I)IW<^G445_GS5JU*]6K
M7K5)5:U:I.K5J3;<ZE2I)SG.3>\IR;E)]9-OJ>XDDDEHDK)=D@HHHJ!A1110
M 4444 %%%% !7BO[1GP.\(?M+? KXK? 3QW$'\+_ !4\%:WX0O[@1+<3Z5<:
MA:L=(\06,4FV-M4\-:S'IWB#26=@L6J:;:2'[G/M5%:T*];#5Z.)P]25*OAZ
MM.O0JP=ITJU*<:E.I%])0G&,HOHT)I--/5-6:[IG^2)\7?A;XO\ @A\4_B'\
M'O'U@=,\:?#+QCXA\$>)K,;VB35O#>IW.EW4UI(Z(;G3[M[?[9IMZJ^3?6$U
MO>0[X9D>O.J_J*_X.9?V._\ A ?C9\//VQO">E>5X9^-MC!\/_B9-;0[8+/X
MI>#=*QX<U2\D 5%G\8^ ;%;&WCCW,TOP]U*\F?SKQ _\NM?Z#<(<04>*.',K
MSNERJ6+P\?K5.+NJ&-I?N<912;YE&&(A4Y.=*4J;A4M::;\.I!TZDX/[+T\T
M]8O75Z65WU3"BBBOI2#[U_X)G_M@W_[#W[8_PF^-[W-U'X(&I_\ "%?%NPMO
M,?\ M3X5^+IK:P\4EK6,;[VX\/NFG^--'LU>-;C7O#.E([K 9*_T_M/U"PU>
MPL=5TR\M=1TO4[2UU#3=0LIXKJRO["]A2XL[RTN86>&XM;JWECFMYHF:.:&1
M'1W5@:_R#*_T"_\ @WJ_;1_X:1_8WA^"OBS5A=_%#]EB73/ 4ZW$^^_U;X5:
MA#=2?"_6"&(+IHUEI^J> F2%6^S6OA+2[J\D\[58R_\ .?CWPK[?!8'BS"T_
MWF!<,NS3E6LL)6J?[%B)V225#$3EAYRWDL517P4K+NP52TI4G]J\H^32U7S6
MOR>_3]]:***_EL](**** "BBB@ K^//_ (.M?^0A^PI_UY_M*_\ H_X"U_89
M7\>?_!UK_P A#]A3_KS_ &E?_1_P%K]-\'?^3C</>F;_ /JCS(Y\5_N]3_MS
M_P!+B?R%T445_<9XX4444 ?Z=?\ P21_Y1K?L:_]D4\/?^C[ZOT5K\ZO^"2/
M_*-;]C7_ +(IX>_]'WU?HK7^=7$W_)1\0?\ 8[S7_P!3\0>[3_AT_P#!'_TE
M!1117B%A1110 4444 %%%% &3KNA:)XIT36/#7B71]-U_P .^(-,OM%UW0]9
MLK;4M(UG1]4M9;'4M+U33KR.:TO]/O[.::UO+.ZAEM[FVFDAFC>-W2OX"?\
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M]_#_ ,(-?\32*.,E8]1\=>$U<C' ,B;O[Z43\5_#ZG%REQ)AFETIX7,JK_\
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M ."%_P#P3*^#TUI?P?L[6OQ)UJTVXU;XP>)_$OQ!AN-A!'VOPIJ.HP^ )]S
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M[-W"6<*1_G)7^B)_Q#R?\$O?^B2^//\ P\?Q%_\ EW1_Q#R?\$O?^B2^//\
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MY1<IXB5X+V<7+JPV'=%RE.SD[)6;=EI?5I:MVOZ>84445^-'6%%%% !1110
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MY/\ @E[_ -$E\>?^'C^(O_R[H_XAY/\ @E[_ -$E\>?^'C^(O_R[KS\U\:>
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M5Y=\9_@Q\,OVA?ACXO\ @Y\8O".E^./AUXZTN32?$7A[58W\J>$NDUK>6=U
M\5YI>L:7>16^I:+K6FW%IJFC:I:VFI:;=6UY:PS)]_X?\>YAP/F2G'VF*R?%
MSA',\N4OCBK16*PO-)1IXRC'X6_=KTU["LTG3J4L*]"-:-MI+X9?C9^3^];K
MS_R4**_T1/\ B'D_X)>_]$E\>?\ AX_B+_\ +NC_ (AY/^"7O_1)?'G_ (>/
MXB__ "[K^A?^(]\%_P#0)Q!_X18+_P">7K_3TX?J5;O#_P "?_R)WG_!!/\
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ME]6S;BZ=*?V?<Q&3Y-4M9^\^3-L53DD[+*VFU*K ****^$/\^0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?]##!_\ A1#R\_/\/6Q_Q&SPB_Z.1P;_ .'[+_\ Y<?F917Z9_\ #I']LO\
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M  Z1_;+_ .A:\$?^%[HW^%']LY5_T,,'_P"%$/+S\_P];'_$;/"+_HY'!O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+2[;6_!^O2ID!Q!JD>IZ[I,1*_=$GAN;YSG?LP@_;G]EO]L#X2?M8^&KO5?
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M_M2ZY\7;#XL7WAV\@\&Z3X/O-#&AZ!;Z*T<^M7?B&&^-R8)9?M"M'IUKY:L
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MWPZ9JEYK7AHL#RK3:%+D@!MZ_+1_;7#-1^SJ91R0=ESQPF$C);*[=.<9J_\
M=G)]D^@_'+Z+.93> QW@LL%@)OV<<=A^$.$</B*<'9<]2>69A0QU)6UE+#XB
MO6O=Q4I.[[?]B3]KN/\ ;!^'OB'Q<W@A_ NI^%/$$/AO5M.76QKUA>W$NF6V
MI+>Z?=G3=,GA@D6XVM:7-M));D&/[5<C][7VI7QK^QU^R+IW[(6@_$'PIHGC
M.]\9:'XO\66WB72Y=4TJ#3=4TJWBTBWTUM.U"6TNI;34YE:V\Y=0@M=,619
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MZ"L#DN0X/#U<QH+%8BLDFITU6<I\L93A2I3M1C"FG;FD^9WNY7M%?Z1T> /
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MYMBJRIU'&K3HQ]O&CA:G[!T445^<G^8P4444 %%%% !1110!PWQ)\>:)\+O
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M#YS2J4:DJ<Z6'P\X2BW=2C.I).SNM]U:S5TUJS]I^EEGF;\/>-^4YKDV88G
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MKD>*J*E-\\:+;4>>$ZD:L73<M)5*5:\O9NSE&W*FE*W]\_1]XLX/\0_"?-_
M3B_,Z>48VHL;2R.I6JTJ,\=A,;CUG.&EE\\1*-*OFF4YVYXK^SY-3Q&&5#V,
M*L*>+^K_ -A8(8!E(((R".00>A!]*X_QUX[\)?#/PGKGCGQWKVG^&O"OARPF
MU#5M6U.X2WM[>"$'9%&#\]U>74FVVL-/MDFO-0O)8;.R@FN9XHF_B_\ !W[5
M7[27P^TJ#0O!WQR^)^AZ):1B&RT:V\8ZS+I5A"BA5BT_3KJZN+.PA '^KLX8
M%KEO&GQ7^,WQKU'3[7QWX^^(7Q,U W*QZ/IFNZ_KOB4QW<Y,:Q:+I,]Q=16\
M\VYHUCT^UC:1F^X^_-1#@RM[5>UQM)4$TW*%.7M7"Z;2C)\D6UNW.2CO:22O
MR8+Z#^<0S6']J\=Y2L@I5N?$5\%EV+CFE7"4Y*4XQH8F:P6$K5*::]K/&8N&
M&D_:.EB8P]G.?X[_ !,F^-'QH^)GQ2>VFMD\<^,];UVPL9MK7%EI5U>NFAZ=
M,8V='GL=(BL;.1HV9))(7=/D>O[ OV0/AG>_!_\ 9E^"WP]U2W>SUC1/!&GW
M6NV4BE)+'7_$4MQXGUZQD!_Y:66LZQ?6LA_C:(OQD"OQK_X)\_\ !-'QC<>+
M?#_QN_:*\.S^&/#OAR[M=<\&_#;6[?RM?\0ZS:NMQIVK>+-*E'FZ+H>F7"QW
M46AZE&FJ:O>0HFIV=MHZ/'K/]$M8<3YCAJL<-EN#E&='"6<YPES4U.,/94Z<
M))M2]G#F<I)M7FE?FC)+Y_Z5WB9PSG%'ACPQX,Q>'Q^3\(2A6S#%8*LL1@(8
MW"8'^R\LRW"8F#=/$2RW SQ4<75I2J4E5Q%.@JBKT,53B4445\B?QB%%%% !
M1110 4444 ?DY_P64_Y-.T'_ ++/X0_]1GQS7Y2_\$D?^3R_#7_8D>/?_3,*
M_5K_ (+*?\FG:#_V6?PA_P"HSXYK\I?^"2/_ ">7X:_[$CQ[_P"F85]YE7_)
M*9A_AQW_ *;I'^A_A+_RA_XB?]@G'?\ ZKJ!_5[1117P9_G@%%%% !1110 4
M444 %?PN_&S_ )+-\7/^RG>/?_4JU:O[HJ_A=^-G_)9OBY_V4[Q[_P"I5JU?
M;<%_QL?_ ->\/_Z<F?WA]!G_ )'7B'_V*^'_ /U+S,_LK_9:_P"38_V<_P#L
MA'PA_P#5?>'J]WKPC]EK_DV/]G/_ +(1\(?_ %7WAZO=Z^0Q7^\XC_K_ %O_
M $Y(_BWBK_DI^(_^Q]G'_JPQ 4445@>"%%%% !1110!_&Q^WS\'[WX,_M6?%
MC0)+1[?1?$OB"[^(7A2784M[GP]XWN;C6HTL\\M;Z/JDVJ>'68\_:='FX?[\
MG[J?\$O/VK_"7Q5^"?A3X,:[KME8_%;X6:4GAJ'0[ZZC@O/$W@S25,?AW5]!
MAE8/?II&C+;Z'J]K;/-=6,NEIJ%S##9ZE9NWM'[<O[%?A_\ :[\#62V=Y9^&
MOBIX02[E\#^*KF)VL;B&ZVR7?A?Q)]GCDNI-!U*:**:&ZMXY[S0[Y?M]E#=0
MS:EIFI?RT_%;X%_&[]G#Q5'I_P 1O!WB;P+J]E>B71?$,:SKI-_/;.9(;_PS
MXKTQWTV_*%%FC?3M0:[M6_=W*6URC(GZ#AYX3B7*J&#JUU1Q^'C#>SJ.=."I
MJK&+<75I58_Q(IQ<)MMV2BY?Z2<.X[@OZ4/A)D? ^<9]2R/Q!X9I8+V?M/8S
MQLL;EN#G@(YMAL'4JX=YMEN9X*7/F6'PM6G/"8QKG]DJ.#JU_P"X&D)"@DD
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M+O\ D7XOUK?^FJ1^N^&__)L^,/\ K[G_ /ZH< ?LI1117@'\\!1110 4444
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M_P!>(?G _P!2/%7_ )1II_\ 8DPG_IND?O71117YL?Y;!1110 4444 %%%%
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=*G^"'Y'ROTK_ /D[^:?]B_ ?E6"BBBOGC^:S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tcrx-20260812.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-08-11T18:06:33.0889+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.tscan.com/20260812" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:tcrx="http://www.tscan.com/20260812" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" namespace="http://fasb.org/us-gaap/2026"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" namespace="http://xbrl.sec.gov/dei/2026"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>75000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="tcrx-20260812.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 12, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001783328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TSCAN THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5282075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">830 Winter Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text"> 857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">399-9500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Voting Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tcrx-20260812.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tcrx-20260812.htm">tcrx-20260812.htm</File>
    <File>tcrx-20260812.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tcrx-20260812.htm": {
   "nsprefix": "tcrx",
   "nsuri": "http://www.tscan.com/20260812",
   "dts": {
    "inline": {
     "local": [
      "tcrx-20260812.htm"
     ]
    },
    "schema": {
     "local": [
      "tcrx-20260812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 23
   },
   "report": {
    "R1": {
     "role": "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "75000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_a8ad3b07-0cee-4afc-afb4-5cad297a2139",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20260812.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a8ad3b07-0cee-4afc-afb4-5cad297a2139",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20260812.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.tscan.com/20260812/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-345732-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-345732-xbrl.zip
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M.R1S0=UQ+*)(C-'',*8Q"VF$+B:U[D$S60L=1A$ZE]DR="XRD5X+WBH+[>=
M#Z!)G+W?F6GZC=%*TJNVYGE>>R33[)2).B,_C7@X32L?54J=$+M=?IQ+FB],
M:I5)\]FDX5P#9E,;;:!C#ET3D_1 ^:^/))>??9I-DX_NI9_KG_PZ21J.'BI7
MD\V00RY'?)(\3N(3&/DT9(NS\3QMY^.A:$-"')<IIZW*PD5M@AYH[3^^?+Y@
M?3&@^&[7N;A#_4RPUE5RW88/;<D0TYYDB:EKSF-4+5-,,N0LG>]\GC$:*[Z5
MY1)7TV^IE&.H=R[UI!VW1&KG*8VS($D'BM4E#2W)Y(8V4\[B]CU6B*YCHF-M
MVM$B3Q_LI->&KSL?_H$.^H)R^(L.\C"/Q <7_WK0+G_*EP.14R6Z6/Q=A-?O
M=[I)G(- XTL8O!W$RJ?W.[D8Y6TE#VU9:+LJ]<!/^!AE^3@2[W>&E$LXZ;C#
MT?Z IE=AW*%%GOPS' R3%,8RW_\WC"H7HP[9QS?"_QKF6):+L_#? E/^5Y'E
M'8V0_]X?)EDH.]U)140E!NWOJ-;R\'I2&0^S843'DA'EUX-PU)%M$FGY,^1<
MQ.KG+:>BD+_?^?@GUZCG.]S'A-HZ-@7AV-6%CP/#,0CAE#BZM8-B.I"UB+!S
M" #')<A]C.A519)1?BX"(-:?U*7<\(F#"1,"FS1@F :^B2U&N>XY5-<,;P>5
MH_A^!X:]$X0CP7% (Q#3#^K/07NNF0^TVK&)85H^=IBK*A+8LXF%#=/S+6HS
M@SC!;*N/8QCD<1>:G=*H)ZG^JQB_J/4?" BFXQJ&[MYK:7N>UJD(1 IJ160?
M#B2X=#(ERU ;4F#3D9#P?B<#CHBD8*MW_50V1@HAGHA;:Y1Q8#15_&R9ZC%+
MBE0]*?#L5#U29%JV1U56H6@T>0JY? Y"D2+5;+%0RKN]7^<I<C?SA\FK^=*'
M0+"$3YX VM)<:L /4P6H3_+=?ILVDS^0=/)E\CRII#U'F@D=IX1KSPA+&V3J
MKFQ-Q%3?'X0Q[@NI0#ND987Q0LF<+X-%- .=.J"0M8(/]1>>1;ISMPIK<8G#
M23H_2:&9.$^&';VE6\,<\:3P(X%^(.K??@!%*P !Y!CF%>ZH]-6W@ [":-RY
M# <B4U;->3*@\22AG^1Y,H"T"HAH%%[%G4@$N6Q$-J3QI!TW_3 7&-XPT1FF
M M^D='BW[L>J4]^^BC26 *DP2Y+V)N1Y'Q AGU *JOWQ!\TF^P=M63N0=CA#
MC(?[:K4<ZXD6/-)A!C6+]&Z761(E:6="YX<)<%/RAY]$?)8B;FT4^>VD=WE\
MA"XN#R^/+P[\M/WAXKC[VWGOLG=\@0Y/CM#Q']U?#D\^':/NZ9<OO8N+WNF)
M2C8A8HV]TFOKU>^'%[_T3CY=GI[LH:-6MP5&K65Z"\>]&CK)EQT3U&-=/%\)
MU^19\1 "PSWD4_&JLBC36]6]P7+2UY\6E"<;L#8QJ5LJ/IZ>?T&+./P9M>TL
MMC5\GW/3<S7L$5-92 ;V0*UBRX:?CL8)Y];+#*%;^V3B.2H[<T.!1]G*%7_=
M-7RJUWV]D=,UZ#-OPY19?; /BNO\^.02G1^?G9Y?/I,LSV$;U>;MH<M9D68%
M^(@H3]"%8"I$I!DH29%F[?)W* E0WA?R4Y&"O0BU'(]8G\970H:IY&?-,\P9
M>H(]"CXOE;;BO"TINR>; UPCOV+P(I,B5Z[J?MDR\$%;($)5>B!11(>9Z&1B
M2%,PMTMG5):>3HJ^#K/0#R.P]SN3Y)-4D(Q/I4X5;Y*6*4L?22+*EDS,9'BU
MK_SKA=DLKV4_F0U\^_1>ZRH+7G'3PB&^@9YB/Q7T:T?]C^6+!1!RKV65RU\R
M9XMHTD.H7BD4)/#B6J1YR&A4%05)IVDF\CN3K40P^69G[2*Q"!B7%8BEF%K%
M.($USX6,@*#=R;.@X)Z)+$?B6@9/4_59\'>K&*Q+-0BM]F\6KMHY?T5^*,N:
M98D[>;0)$JU!WT[5[;R:)2W#<Y_4M/6.WRR'+#;>A.,PT],<;#G"QR:S;>P&
M1H!=+S!=1YB.:8BZC+<S%6\X+J,0\V$N#F_P &KIRVR8TS$> ]MC$:^3/H?%
M50%BI>E[:H[@*>MMEHVGR D_I%ZH'7TV.<:PN<I2Q8-74'JZ6;O2FXE)S6+#
M'/;= [X6<:REP>]A +H'BZK4Y51E[1&BVZH4E1_P)KV >Z;OZI@QR\4FL4Q,
MB<TQT37-$H'I4,-9%9#*:/>YN HS.6V2G\"7NBS=I23J\J)[>((N?SD^/SP[
M_NVRU[W80[V3;FL)!%HP<HX<\=FA,YXU=/6:_DOU?_=X1,$,ER,B#9QT.A*(
M9B@;"B9CXQR%,0KS#('A#O9.^FY+@;@^K^=%SG&C=-:N=+R6YCWM;"W(V"+Z
M"[+IY*7UN2W->4E&4VN9VM--?2UW$H9$LL7['6-G.UW+1[3E8JU(0!A8H%%,
M+)]CTQ8&]H) PQ;U!6$>#YA.Z]&*O9@E*3B8:AG!10[BT4V*.$_'W83/&^UR
M:8.<?LS%,$VN93DOMM9?ID6/1$1O:"J>8[=O;SCBV3SCN]PA)M<P-0P-FX'M
M8E_8!)M&8'B<:A1XHQZ>^1A& NKV1?JJXT\(=(O8Q&@88+$I3;D6:,*&(71M
M;.J>AGWN P,XOO T7;>(X]?# )=TU*N6-# %'-^ &\!EL'17!Q?G17[\ I7E
MO#&-=<]/J(G[UN,B*-TC(_I)WA<I^JM(PXR'*M2OINO!;PAG==5B]^#;BOMV
M4;R;# 9A)I?\(HGHJ!3BAJZKTK5W?H&.!\,H&8M4L>X\5J*3I/6$;SL+3M_S
ME,P20[?B8-UWL3>$Y1NR-61KR-:0;3UD:R(WZW+"6."8INUYV-8LBDV-<.QQ
M1K#G$>F!"^;KK!XG[)#S5&19]>=S& OM=1TP@Z#?0TD1=)&G0N3/=LNGW*&_
M/>YH9'@;1FFQ#!N>J3'39CC0#1^;.J'8H\3".K==3C7=='2S5AGNPL_3]#*Y
M>=V ZN\TROMT\(3<OEY[]I98P,*$;^FV[V&-41N;AJ5C*FP8)5MGIO!\FVE&
MK6.CXA*GZ5F:7(=JP^$FA<2_T"RCK%]D(L^S[S L^KPYRV]L;)8=V BZ+36?
M0"PJ'$/#FJ=Q; 92TICA8$>C@0E28UO,JU72SA(0I>C_PZ&:>GK5F07=M+0F
MC/P6@F\5+\EE)L,4 #L<T@B)D6"%W#T(KX.0B6P3@YQ;:X@VL>'EV1/0#4EX
MV];%3=_E@A_3;)DOVI-AM:P-WY2AZ=9F(]NK[\JX72;ZXP^NKCG[&<I%)(9]
MR(1B-46V)V<BHT+V'5$@/NAI+KX=-&[?[H?%!J=.#,NP#1LS3X;./,W"U.(^
MMFUN2]O1\,3*!J?TM ]AR%8P,9?;BN%:SAK\ZKJV@7"7,]TA%G:(;F#3I0'V
M&;>Q'SBZ%IBFHSLKD_IS HQ\)L5FI=4A2W79\#SL680T6SJV7MFNNJ5C#2IS
MF2T=JVG2I;=T?"OO8;W^]TF2H\/A, )" <\]=_O#M]OWO)S-_S%) 8:JW0^I
MBA_"(RT=5; E E1N509^DQ%&%-%LLNNS1C?!:QG/V^)CUV=XU0UGW;Y@7]6.
M;SH<I@DX^G+M&" $\D64W$B2RH^2\,C%OZ( P =LM3!#<KXJYD#J/ %J#XHH
MI[%(BBP:HXSF81:,5<XJ0^)#U\M%.]4.\YFM*P64 \,8CR?? L"VY$;FD]'@
M4"ZLRCJK:/NZR88>50"SYU,HN*]-(\Q9ABK?BCKB)7L:C!?D\;17545/>6MU
M>FH+,7 )&+%?ODU05?ZX"V!1W^4&=;%MP7^F85K8%0[%0G-,:G!A>][*LSN_
MIV$.PRA7/Q9QM28ONS^MXR=)Y%.0Z!R&>YWZX<<?/,<T]VN9O5D3ATRP?[W\
ML2&3.6^.AK5R:R4]((.SXH.&,P>TG!>@5$S=JC3DG8-9Y'DLNYJ#NA_/D6Z0
M%B1\QFK8!EE?B*RF,(C&/0LS[OG8]!F@I$8-3'2/6):F>V+UV;P+\%@8C')\
M]074/AAE40.KFPD)#:QN&*S>B@X:5+)S'U,UDV)-GX'5N4.NIJ!JDE:9LL'5
MU[!838?KE&'N6Z;<J>M@E_@!MJGC!<)GOJ>OO.GN+!726I7''*M#$:4'FYX&
M@3PQM\'73<2&!E\W#%]!A#";D:$G[5?-Y%C?]=\MA[9EV@9OUX^W+-!='A =
M^ZZC85/X&O9]Q\,!<TS..;7<P*T9;WM95HBT0=V-1XP&=;<>=0V03WF'SS*H
M6Z6M<X[D6;3T-G>"9";>4LY8B%3P.7)/3]%52JZ:P0 2=[9BDMAP7W(<TDOR
M6*]4D?ET15M[>N_=V6W].YO>5H< 7,I;E<KC?5F_O ?E%9>,/3P$Z(= _2-&
MLWVC8>X7G&V94MG)\N:5\0!R[[[J\OJ&LQO.7B-LGU1GEBK4%A-;% PGJ W>
MW%I7WW2/[EO;M/+0OES'Y]PAF'/7Q*9O.-@W73FE906N17V;47WE.:S2<AYK
MNJ\T]CK=H_]+5,!?QAJ H2[RA'W=0V @HVL:%0+]%PPA(1H:RCOG^M_GP8=O
M 4<W4I:$$?B:L -,/ ZRI#D!]@G7L659GB!^X#MLY3WNE6E06@7K%*3+[OD?
MC7 TPE&7<'#']32?@J)Q/1V;KDDP-;B+F>]R*FRF@QZJ2]%,XEOJ4/I[@65I
M<:QTKL!R\M,7Z(1FG/Z-/D6)3R/TA:9?1;Z'/G_NKGU/Q9,GIC\RFO)6X# 8
M;TK<K1=S&=P4R!\CIA8I0]N_@JTHU*&6=U80AQF")@N@YY6T Z[2Y";ORQCI
M4*XJIAGB(@CC\F#\<E$5L19<=75[PY6!=J4 ._MRZYKA[:OU59,\H3I9?RA/
MUI?+T,MXJ^YC?<G;L^Z6+4.PM]EG2F]MZIKGM>+*W-S5M^[U\0,\]<2-D$\U
MX($[/)AI>8'-!38\VY2K=CEV2:!CS[08\YC+W2"HYZ2(2;\^J6YURUZM9SJN
M_BU8GF/:R\S<U3Y1<7?3RZ:!9O (#,J]M@LQ-;RW(:,/B"DBP7) S#A1LQQ%
M)E0JZ'NU[0-2EC=*H_(Z;,D[JJYH+"N_":%J*2DQ= 2^I.(ZS" ?X#"-F5R5
M11F3!^3+Q%E.8TY3GI4;/OA#4RS&+IU.L<PB:VM-\DAM3S=UV\',=L!\<3P#
M^X'I84\PFYBN"*BWLOE2R>/H<DK0\KJO+1+&I:;1:U<9\U&UQ=>6;^Z^T2=N
MA \B,<(\3$O.EQ-YQ2#>YV$VC.BX([_>OS2^0J-)K2H5!FE]XC;Y_C2>5E$X
MC",PEC (95I-1<Y_@"++UT-Z)<KP&K X&"P=&MW0<5;-LVW65?=+W5K]U)W&
MC^[KVS1ED(L!TEM$1^<B*Z)<G>1S"EA=+1D Q$4?IV#<34 YR ^W5VG).Y>7
MH=ISI+9>DE71Z%CB9+0>*I[&Z,YEAWOH\H)!6\'5@X:( ESS; _U8M8"-R0K
M0'51T&+RY"1@/T%!;](X!D4GY_G5K5RW&C"M!D9J3JG2 .1A&-#?A;JV"Y6*
M]G^+6""#E)6WT"&HF^%TI^1\1> Z! 5T*NO+5DCGHQ_Z88X\KZ5)/:J<BVZ1
MIG(%2759JCRSOMK=V0S]/5\^C$LE+*T/\!V?(*"2J3FBTSRG3(X&,(N $;BS
M<=87LP,&F;,^Z'<PF4+EY<)G+L"<XTBZBCI0.XP$5[^U?<4U8"4!V@DEVU,K
MR5W2#]V3/ )VB&K-KLQ055/#@975P*@!Y\#6)>ITU&HDJ42JZ:_U^&PS?:VO
M*VLR"]18OIM>UW$#1C+*"O\O&,Q29 6*0JK6\X3E..=]FDNHD 3= _L\K;@&
M>.Z686YO^( 'L/=3$0 'RDWQP,;2+*\V9C^XLZR*@\SRR!Y*[J\DVY.. YCN
M4756G"S[2H!B!GR;NV8$19"E (M!MB K6+]J H!G$:O<8J3@+!K?:WUULR&;
M[\9,(<^'KF?&RK9 UWLMHLUH='7<JEPKF,W"4K9EE'H%&937WD^HTQ!G@1*\
M/8Y!5+JM-*SA!2#4K9U9PM M!MU1<'N*#V4\0:FQSBRMM_H0!>TERQ1=[^TN
M4WSR6+57FL);[ZJ6B:%WDK2^W33?&Z7MD<A8&@[5G65O>3G0Q@_?4J,E79WO
M1 0HZJ<RSINS=(3%R//^U%K]?/ P=8-@,767\HR6W1L"QO/Y- :@8A!@-#\4
MIMA#7-G5=^(:MR!&&V';8&'3B/F=R-K:2-A-H//H3/JB/;F&A3)UI/D1S6EY
M@>.N&/B"R["(G,92@1^95(GG'S^??T8\887TK9K3IYN)C6\\L5$S:U6G&ZYO
MQ7CM._1ZGTX.+W\[/[Y8XVSC?:IL6 3H;&:ZO)S-_[L (2OC/\N&@Q<L ^!%
M-$:,%G+J7D6_R^,T*]\^ TK !QD<AVI\T:=1($T/69 R:*H$,OI=Q)!'%0<B
MUD]2( "?=9PV=X_D2PY)?-$Q]R_*L^'GXF_5DM9F'7!#M(9HZR::V3*>%30O
MT[^F@_"0Z]Q<-MXP>D.TAF@-T3;[IMV-&9?GJKK7C8,=@7/4V0+NWFPJWHFC
M-_1<D9X_CU>ZZ^'YFYFV[_2'S1[ =M9&G^AU&*,OE/TL:-[?0V?]UM$SS.>W
MK!.V1%<W1&N(]ET2K>4\[_#">U,#:P?8Q> J#]GI]D,1H./I+<VGZI;F5'W;
M/9M>XWPO03./>9\_F[XV?=WVOK[UN?B#MI_P\8=_'+3[^2#Z\!]02P,$%
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M!U%0(*,::^L'TD?AI!J5*DUG':C],$#VL<$@CT"+JI9C5I7RK-U^'OFT B^
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M<F[+\%$SC=S+V,CMO)6)B%(>N*8#4!IXRL51'&94]<U7\FV=YUT<\=DVND1
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MFH](QJ%+#)B?AE9<*K<;T5Y3+ &<;[R;</?!]IFH2T(*$MH\62NWADH"CD&
M6!39)*7]'&TF:2'?'%^^@_$.@%G&5#<@#KD[X1&=%QIZZC XGL"]$3#3$<^2
MA0(@K!NG(W;R\<OE*0/> J%4FXF#*?M@D_7#:$N$,I)@;A^_7+_[>GYQC:#!
M1Z5]S/P@.7L?ABYY$I?8\KF+*8KJ;#?N4;Z_/#_5]M01V5/G:1)ZDTD:8#V
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MW^RK(" Z=TC?6;U>*_,=T)LPV ",0(R:8NU'=7431H,C*J\1T@U<OD?)#<5
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M$U](U#XBA@B94'9IF(Q%S+S "2?"8('0A_^T!;"G$+E[TFH+X!E+T&UH[7\
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M(S.D#B[""7#6]$?);D*ZX2W?MTE"YQOSI$PYNF5I!)^).Q$[GA3X+LYUF-*
M;GD<\R"1#-K%4I%^BI_RN4V?A68#ZAM8TTE]JNR/32YO" 5+>8=UC74OA77P
M"R[]=AWL6<#E<?.=]?Y0A\\BA.O=X/S?PL]\//^B<C1W??MLZ(N[FNO%*&B
M*H %Z20X<ST9^7S:QV^IJTPWF/46\,MOJ4R\X33OE9ZJ@2RO *=7I?['A:;)
MZ.<%OA< 61(>)WV>)N'9_!?0I/HXXB.A%$R-#X&\?>[?\JDDE?+VS2!TIS__
MX>V;<3+Q?_Y_4$L! A0#%     @ Z%D,77@UP=J(%   ?[\  !$
M     ( !     '1C<G@M,C R-C X,3(N:'1M4$L! A0#%     @ Z%D,7??_
M@=6K"0  @G@  !$              ( !MQ0  '1C<G@M,C R-C X,3(N>'-D
M4$L! A0#%     @ Z%D,7?>.\M+J(P  "1L"  \              ( !D1X
F '1C<G@M97@Y.5\Q+FAT;5!+!08      P # +L   "H0@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>tcrx-20260812_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcrx-20260812.xsd" xlink:type="simple"/>
    <context id="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2026-08-12</startDate>
            <endDate>2026-08-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_d1a9b7db-0a62-4e0d-82eb-f37300da0725">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_d760345b-7c8e-4afe-9605-349b5a6c307f">0001783328</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_bbdd4981-9042-4e03-9ad3-56e0371d0dd5">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_e77c4917-57eb-4c66-8f3f-89f487e4743e">2026-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_9fd94b82-cc58-4054-a06d-02115ef47a37">TSCAN THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_0160cf1a-05bd-46e3-9ff1-5abe0c9dfc2a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_b8d704d1-a331-4f68-be60-43f39da1ab07">001-40603</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_9ad1f1e6-af86-4291-bdb0-47be9122507b">82-5282075</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_cf744699-615a-410d-9dc0-9901ab0ecb2c">830 Winter Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_3941c46c-f23b-420a-9a05-2d68da124724">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_ceb526b9-1ca6-4352-ae6b-462c4e9b6c13">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_b05ae731-191d-4f52-ac37-71af497a65c9">02451</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_20353636-c95a-4915-a5db-66d697a239e9"> 857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_d8dc2705-7023-48af-bcd6-bf721f447279">399-9500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_5ab8d3a8-65a8-4345-8e7a-e174a3de6993">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_4e301d95-cd9b-4bcc-a1a3-029055129ec9">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_5a47d2ac-db54-46e7-80bf-6a79febcb92b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_cf28df02-b871-4eb1-bb79-fc74ddda58f8">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_397bdd70-dd84-4b37-b485-cd5f85ab6ca2">Voting Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_e3fb1e6f-09d4-417f-b0d2-5559e0bfb7c4">TCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_d7891ba0-d892-4840-a3d8-cb8dae6c27bd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_c459f6de-3964-434d-80f2-945cc9c8d8ff">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_a8ad3b07-0cee-4afc-afb4-5cad297a2139"
      id="F_a6924267-c672-4793-bf49-9ec6048efa9d">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
